MJ Unpacked’s Atlantic City Agenda Is a Stress Test Wrapped in a Trade Show

What an industry event’s session lineup tells you about where legal cannabis actually stands heading into Q2 2026.

Trade shows are industry X-rays. The sessions that draw the biggest rooms tell you what operators are scared of; the sponsorships tell you who has money to spend; the absence of certain panels tells you what nobody wants to say out loud.

MJ Unpacked’s May 5 Atlantic City show — the largest B2B cannabis event on the 2026 calendar — released its session agenda this week. Read it carefully enough, and it’s a reasonably accurate stress test of where legal cannabis stands right now.

Here is what the agenda actually says.

The Banking Sessions Are Back, and Nobody Is Pretending It’s Solved

Multiple sessions are dedicated to cannabis banking and financial access — a perennial fixture at industry events, which itself tells you something. The SAFE Banking Act has been Cannabis Inquirer’s legislative tracker, amended, and reintroduced in multiple Congresses. As of today, state-legal cannabis businesses still cannot reliably access federal banking services, SBA loans, or institutional investment.

The CLIMB Act — currently in the policy pipeline with bipartisan support — would expand access to lending and investment specifically. But the trade show sessions are focusing on practical workarounds: cannabis-specific credit unions, state-chartered financial institutions, and private credit structures that don’t depend on federal resolution.

That a major industry event in 2026 still requires dedicated panels on “how to have a bank account” is not a sign of a maturing market. It’s evidence of how badly federal policy has stunted normal business development.

Price Compression Is the Subtext of Everything

Sessions on operator profitability, license valuations, and small business survival are all, at bottom, sessions about price compression. The legal cannabis price floor has been collapsing in virtually every mature market for three years. In Illinois, sales fell to four-year lows in 2025 — and January and February 2026 data came in worse.

The Whitney Economics projection of $30.5B in 2026 national legal sales is being read optimistically, but the projections show volume growth, not margin growth. The operators who can’t survive on compressed margins are the small ones — the the equity licensing crisis license holders, the independent cultivators, the single-dispensary operators who were told legalization would be their opportunity. They are the ones most likely to be absent from MJ Unpacked because they can no longer afford the registration fee.

M&A Sessions Without the M&A

There are sessions on M&A and consolidation on the agenda, but the candid reality — acknowledged in industry media if not always in investor decks — is that the M&A market in cannabis is largely frozen. The reasons are structural: 280E tax exposure inflates effective tax rates above 70% for some operators, making accurate valuations nearly impossible. Private equity is reluctant to touch assets with unresolvable tax liability. Strategic acquisitions by larger MSOs are slowing because most acquirers are managing their own margin problems.

The ESOP structure has emerged as one of the more functional exit paths available — we covered this earlier this month. But an industry where employee buyouts are the most viable liquidity option is an industry that hasn’t found its normal capital market footing.

The Beverage Question

the federal hemp ban Farm Bill framework technically permits these products; the FDA has not acted decisively to restrict them; and the alcohol industry is actively lobbying to bring them under their regulatory umbrella.

For cannabis operators, the beverage opportunity is real but treacherous. If Congress defers to alcohol regulators, the licensing structure for hemp THC beverages will likely favor alcohol distributors over cannabis operators. That’s not a paranoid read — it’s what Big Alcohol’s own lobbyists have been requesting.

What the Absence Tells You

The sessions notably absent from the agenda: anything on Schedule III rescheduling timelines. Anything on DEA process. Anything on the MOCA Act’s April markup. The federal reform conversation has been pushed to the policy track rather than the industry track — which suggests that operators have largely stopped planning around federal resolution on any particular timeline.

That’s a strategic adaptation. It’s also a concession.

MJ Unpacked Atlantic City runs May 5–7 at the Hard Rock Hotel. Registration is open. The harder question — who in the industry can still afford to be in the room — is not on the agenda.

Caleb Quinn is the Industry Editor at CannabisInquirer.com.